Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J S Leeder

Showing results (1-10 of 76) with videos related to

Pageof 8
Sort By:
Epilepsia|November 3, 1998
Mechanisms of idiosyncratic hypersensitivity reactions to antiepileptic drugsJ S Leeder
Pediatric Clinics of North America|June 20, 2001
Pharmacogenetics and pharmacogenomicsJ S Leeder
Clinical Pharmacology and Therapeutics|October 30, 2009
Developmental pharmacogenetics: a general paradigm for application to neonatal pharmacology and toxicologyJ S Leeder
The Pharmacogenomics Journal|June 26, 2002
The challenges of delivering pharmacogenomics into clinical pediatricsJ S Leeder, G L Kearns
Clinical and Experimental Immunology|January 1, 1995
In vitro analysis of metabolic predisposition to drug hypersensitivity reactionsR J Riley, J S Leeder
Clinical Pharmacology and Therapeutics|September 6, 2012
Interpreting pharmacogenetic data in the developing neonate: the challenge of hitting a moving targetJ S Leeder, G L Kearns
Clinical Pharmacology and Therapeutics|February 23, 2007
Application of pharmacogenomic strategies to the study of drug-induced birth defectsJ S Leeder, A A Mitchell
Pediatric Clinics of North America|February 1, 1997
Pharmacogenetics in pediatrics. Implications for practiceJ S Leeder, G L Kearns
Clinical Pharmacology and Therapeutics|June 11, 2015
Genetic determinants of fetal opiate exposure and risk of neonatal abstinence syndrome: Knowledge deficits and prospects for future researchT Lewis, J Dinh, J S Leeder
Drug Intelligence & Clinical Pharmacy|May 1, 1984
Glucagon therapy for beta-blocker overdoseC D Peterson, J S Leeder, S Sterner
Pageof 8

Showing results (1-10 of 76) with videos related to

Sort By:
Pageof 8
Epilepsia|November 3, 1998
Mechanisms of idiosyncratic hypersensitivity reactions to antiepileptic drugsJ S Leeder
Pediatric Clinics of North America|June 20, 2001
Pharmacogenetics and pharmacogenomicsJ S Leeder
Clinical Pharmacology and Therapeutics|October 30, 2009
Developmental pharmacogenetics: a general paradigm for application to neonatal pharmacology and toxicologyJ S Leeder
The Pharmacogenomics Journal|June 26, 2002
The challenges of delivering pharmacogenomics into clinical pediatricsJ S Leeder, G L Kearns
Clinical and Experimental Immunology|January 1, 1995
In vitro analysis of metabolic predisposition to drug hypersensitivity reactionsR J Riley, J S Leeder
Clinical Pharmacology and Therapeutics|September 6, 2012
Interpreting pharmacogenetic data in the developing neonate: the challenge of hitting a moving targetJ S Leeder, G L Kearns
Clinical Pharmacology and Therapeutics|February 23, 2007
Application of pharmacogenomic strategies to the study of drug-induced birth defectsJ S Leeder, A A Mitchell
Pediatric Clinics of North America|February 1, 1997
Pharmacogenetics in pediatrics. Implications for practiceJ S Leeder, G L Kearns
Clinical Pharmacology and Therapeutics|June 11, 2015
Genetic determinants of fetal opiate exposure and risk of neonatal abstinence syndrome: Knowledge deficits and prospects for future researchT Lewis, J Dinh, J S Leeder
Drug Intelligence & Clinical Pharmacy|May 1, 1984
Glucagon therapy for beta-blocker overdoseC D Peterson, J S Leeder, S Sterner
Pageof 8